Nifty

:

24238.50

Sensex

:

77708.52

-95.80 (-0.39%)
-442.93 (-0.57%)

Login

Nifty
Sensex

:
:

24238.50
77708.52

-95.80 (-0.39%)
-442.93 (-0.57%)

Zenotech Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

47/99

BSE: 532039 | NSE: Not Listed

Watchlist

NSE BSE

47.71

20-Jul-2026

Open
High
Low
Previous Close

45.55
48
45
46.17

Volume
Traded Value (lacs)
52 Week High
52 Week Low

18874
893295
48
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

291.18
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

260.75
N/A
3.06

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

34.51
3.58
2.22

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-12.08
-11.81

PAT CAGR (%)

10 Years
5 Years
3 Years

-25.33
-
-

P:E (Median)

8 Years
5 Years
3 Years

33.06
45.11
60.86

P:BV (Average)

8 Years
5 Years
3 Years

4.31
4.43
3.99

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.15
20.73
21.15

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 9.88 12.13 -18.55% 12.85 11.24 14.32% 11.24 9.76 15.16% 9.64 9.91 -2.72%
Expenses 9.71 7.66 26.76% 8.59 7.37 16.55% 8.95 7.36 21.60% 7.18 6.48 10.80%
EBITDA 0.17 4.47 -96.20% 4.26 3.87 10.08% 2.29 2.40 -4.58% 2.46 3.44 -28.49%
EBIDTM 1.75% 36.84% 33.17% 34.45% 20.38% 24.63% 25.53% 34.66%
Other Income 0.60 0.49 22.45% 0.42 0.37 13.51% 0.70 0.34 105.88% 0.59 0.34 73.53%
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 1.76 1.73 1.73% 1.80 1.76 2.27% 1.78 1.75 1.71% 1.77 1.73 2.31%
PBT -0.94 3.19 - 2.59 3.11 -16.72% 1.26 2.35 -46.38% 1.28 2.05 -37.56%
Tax 2.21 1.96 12.76% 0.66 1.42 -53.52% 2.09 1.00 109.00% 0.29 0.76 -61.84%
PAT -3.15 1.23 - 1.93 1.69 14.20% -0.84 1.35 - 0.99 1.29 -23.26%
PATM -31.88% 10.13% 14.98% 15.07% -7.45% 13.81% 10.26% 13.01%
EPS -0.52 0.20 - 0.32 0.28 14.29% -0.14 0.22 - 0.16 0.21 -23.81%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales - 43.61 43.05 40.83 42.42 36.57 22.45 26.02 13.03 11.14 2.25 Net Sales Growth - 1.30% 5.44% -3.75% 16.00% 62.90% -13.72% 99.69% 16.97% 395.11% Cost Of Goods Sold - 0.00 0.84 0.00 0.06 0.00 0.03 0.50 0.72 0.80 1.66 Gross Profit - 43.61 42.21 40.83 42.36 36.56 22.41 25.52 12.31 10.35 0.59 GP Margin - 100% 98.05% 100% 99.86% 99.97% 99.82% 98.08% 94.47% 92.91% 26.22% Total Expenditure - 34.43 28.87 23.62 21.72 19.10 16.07 17.04 16.55 19.01 12.66 Power & Fuel Cost - 3.24 2.71 2.69 3.79 3.25 3.12 3.29 3.68 4.24 1.94 % Of Sales - 7.43% 6.30% 6.59% 8.93% 8.89% 13.90% 12.64% 28.24% 38.06% 86.22% Employee Cost - 15.53 12.38 9.46 7.88 7.10 6.49 5.76 4.98 5.07 3.02 % Of Sales - 35.61% 28.76% 23.17% 18.58% 19.41% 28.91% 22.14% 38.22% 45.51% 134.22% Manufacturing Exp. - 11.92 9.44 8.66 7.63 6.59 4.55 5.61 4.64 5.18 3.00 % Of Sales - 27.33% 21.93% 21.21% 17.99% 18.02% 20.27% 21.56% 35.61% 46.50% 133.33% General & Admin Exp. - 2.86 2.91 2.35 2.02 1.95 1.34 1.72 2.18 3.52 2.90 % Of Sales - 6.56% 6.76% 5.76% 4.76% 5.33% 5.97% 6.61% 16.73% 31.60% 128.89% Selling & Distn. Exp. - 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.06 0.04 % Of Sales - 0.05% 0.05% 0.05% 0.05% 0.05% 0.09% 0.12% 0.23% 0.54% 1.78% Miscellaneous Exp. - 0.85 0.57 0.43 0.31 0.19 0.50 0.12 0.32 0.15 0.04 % Of Sales - 1.95% 1.32% 1.05% 0.73% 0.52% 2.23% 0.46% 2.46% 1.35% 4.44% EBITDA - 9.18 14.18 17.21 20.70 17.47 6.38 8.98 -3.52 -7.87 -10.41 EBITDA Margin - 21.05% 32.94% 42.15% 48.80% 47.77% 28.42% 34.51% -27.01% -70.65% -462.67% Other Income - 2.31 1.55 1.01 1.08 0.63 0.41 1.17 4.71 2.37 0.08 Interest - 0.00 0.00 0.00 0.11 1.22 1.55 0.89 0.12 2.45 7.50 Depreciation - 7.11 6.96 7.09 7.17 6.97 6.46 4.85 4.20 3.90 3.87 PBT - 4.38 8.77 11.14 14.50 9.90 -1.22 4.41 -3.13 -11.85 -21.70 Tax - 5.26 5.08 2.84 2.92 -12.27 0.00 0.00 0.00 0.00 0.00 Tax Rate - 125.84% 47.52% 25.49% 20.14% -123.94% 0.00% 0.00% 0.00% 0.00% 0.00% PAT - -1.07 5.61 8.30 11.59 22.18 -1.22 10.78 -3.13 -11.85 -19.87 PAT before Minority Interest - -1.07 5.61 8.30 11.59 22.18 -1.22 10.78 -3.13 -11.85 -19.87 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - -2.45% 13.03% 20.33% 27.32% 60.65% -5.43% 41.43% -24.02% -106.37% -883.11% PAT Growth - - -32.41% -28.39% -47.75% - - - - - EPS - -0.18 0.92 1.36 1.90 3.64 -0.20 1.77 -0.51 -1.94 -3.26

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 95.12 96.13 90.54 82.27 70.64 48.41 49.63 38.90 42.02 -65.91 Share Capital 61.03 61.03 61.03 61.03 61.03 61.03 61.03 61.03 61.03 34.43 Total Reserves 34.09 35.10 29.51 21.24 9.61 -12.62 -11.40 -22.13 -19.01 -100.33 Non-Current Liabilities 3.98 -1.63 -4.38 -7.36 -4.41 22.49 0.49 0.34 0.28 0.24 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 6.00 20.66 0.00 0.00 0.00 0.00 Long Term Provisions 2.15 1.34 1.17 1.02 0.89 0.83 0.49 0.34 0.28 0.24 Current Liabilities 12.06 12.59 13.52 16.61 15.58 14.95 35.44 45.35 39.45 116.42 Trade Payables 3.70 2.52 3.29 3.48 2.07 1.92 4.60 4.12 5.41 5.13 Other Current Liabilities 3.88 4.39 3.87 4.86 5.22 4.59 3.68 3.79 17.26 41.72 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 18.66 20.24 0.00 51.20 Short Term Provisions 4.48 5.67 6.37 8.27 8.29 8.44 8.50 17.20 16.77 18.36 Total Liabilities 111.16 107.09 99.68 91.52 81.81 85.85 85.56 84.59 81.75 50.75 Net Block 62.29 60.87 65.58 65.38 70.91 74.23 48.73 43.11 44.43 46.83 Gross Block 124.83 116.29 114.05 106.78 105.13 101.48 69.52 59.05 56.17 54.67 Accumulated Depreciation 62.54 55.43 48.47 41.39 34.22 27.25 20.79 15.94 11.74 7.84 Non Current Assets 70.11 71.10 73.52 75.25 74.43 78.50 79.85 65.39 50.32 48.93 Capital Work in Progress 3.60 3.57 1.96 4.98 0.28 2.18 29.08 16.95 2.32 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 4.22 6.42 5.75 4.79 3.15 1.98 1.94 5.33 3.56 2.10 Other Non Current Assets 0.00 0.24 0.23 0.10 0.10 0.10 0.10 0.00 0.00 0.00 Current Assets 41.04 35.99 26.16 16.26 7.37 7.35 5.71 19.19 31.42 1.82 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 0.00 0.00 0.84 0.00 0.06 0.06 0.09 0.58 0.82 0.92 Sundry Debtors 8.78 7.45 3.25 3.32 3.93 3.80 1.86 2.36 0.00 0.00 Cash & Bank 30.42 26.70 19.69 11.14 2.41 2.46 1.12 13.25 29.16 0.68 Other Current Assets 1.84 1.28 1.67 0.97 0.97 1.02 2.64 3.00 1.44 0.21 Short Term Loans & Adv. 0.63 0.55 0.71 0.83 0.43 0.79 2.39 2.50 0.89 0.06 Net Current Assets 28.98 23.40 12.64 -0.34 -8.20 -7.60 -29.73 -26.15 -8.03 -114.60 Total Assets 111.15 107.09 99.68 91.51 81.80 85.85 85.56 84.58 81.74 50.75

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 10.20 9.49 11.82 20.66 17.67 5.74 11.38 -14.04 -16.25 1.64 PBT 4.19 10.69 11.14 14.50 9.90 -1.22 10.78 -3.13 -11.85 -19.87 Adjustment 5.60 3.63 6.17 6.86 8.01 7.66 -1.68 -0.07 4.63 9.55 Changes in Working Capital -0.16 -2.89 -4.41 0.49 0.76 -0.59 2.56 -10.38 -8.75 11.86 Cash after chg. in Working capital 9.63 11.43 12.90 21.85 18.67 5.86 11.66 -13.58 -15.97 1.53 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.58 -1.94 -1.07 -1.19 -1.00 -0.12 -0.28 -0.46 -0.28 0.10 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -6.49 15.29 -21.15 -5.82 -1.84 -4.82 -20.79 -16.19 -2.65 -0.69 Net Fixed Assets -8.57 -3.85 -4.25 -6.35 -1.75 -5.06 -22.60 -17.51 -3.82 -2.54 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 2.08 19.14 -16.90 0.53 -0.09 0.24 1.81 1.32 1.17 1.85 Cash from Financing Activity 0.00 0.00 0.00 -6.11 -15.87 0.45 -2.70 15.02 46.83 -0.72 Net Cash Inflow / Outflow 3.71 24.78 -9.33 8.73 -0.04 1.38 -12.11 -15.21 27.92 0.23 Opening Cash & Equivalents 26.58 1.82 11.14 2.41 2.46 1.08 13.20 28.40 0.48 0.25 Closing Cash & Equivalent 30.29 26.58 1.82 11.14 2.41 2.46 1.08 13.20 28.40 0.48

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 15.59 15.75 14.84 13.48 11.57 7.93 8.13 6.37 6.88 -18.17 ROA -0.98% 5.43% 8.68% 13.37% 26.45% -1.42% 12.67% -3.76% -17.89% -38.33% ROE -1.12% 6.01% 9.60% 15.15% 37.26% -2.48% 24.35% -7.73% 0.00% 0.00% ROCE 4.38% 11.46% 12.89% 18.39% 15.26% 0.48% 18.32% -5.95% -61.88% 0.00% Fixed Asset Turnover 0.36 0.37 0.37 0.40 0.35 0.26 0.40 0.23 0.20 0.04 Receivable days 67.92 45.38 29.38 31.20 38.59 46.02 29.56 33.08 0.08 28.21 Inventory Days 0.00 0.00 7.51 0.00 0.61 1.27 4.76 19.68 28.57 203.13 Payable days 0.00 1263.19 0.00 0.00 0.00 0.00 3153.54 94.45 98.95 125.78 Cash Conversion Cycle 67.92 -1217.81 36.89 31.20 39.20 47.29 -3119.22 -41.68 -70.30 105.55 Total Debt/Equity 0.00 0.00 0.00 0.00 0.08 0.43 0.38 0.52 0.00 -0.82 Interest Cover 0.00 0.00 0.00 130.25 9.15 0.21 13.08 -25.57 -3.84 -1.65

Description Mar 10 Mar 09 Mar 08 Mar 07 Mar 06
Book Value (Rs.) 26.10 29.12 33.76 16.03 9.90 ROA -10.38% -12.37% -12.69% 1.92% -4.87% ROE -12.51% -15.42% -18.61% 5.07% -22.00% ROCE -9.32% -11.74% -9.54% 1.68% -4.60% Fixed Asset Turnover 0.09 0.09 0.13 0.56 0.80 Receivable days 61.38 69.41 241.73 116.82 136.09 Inventory Days 137.65 232.92 227.91 61.65 64.93 Payable days 69.38 76.16 111.09 146.73 212.90 Cash Conversion Cycle 129.65 226.18 358.55 31.74 -11.88 Total Debt/Equity 0.11 0.16 0.16 0.73 1.92 Interest Cover -5.41 -7.53 -3.84 0.52 -3.89

Top Investors:

padmasree chigurupati

pat financial consultants private limited

dr. jayaram chigurupati

minal bharat patel

Annual Reports:

News Update:

Zenotech Laboratorie - Quarterly Results
30th Apr 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback